Publicação

Chronic and Refractory Migraine: How to Diagnose and Treat

Ver documento

Detalhes bibliográficos
Resumo:Migraine is highly prevalent and carries a significant personal, social and economic burden. It is the second cause of disability (years living with disability) worldwide and the first cause under 50 years of age. Chronic migraine (occurring for more than 15 days a month) and refractory migraine (treatment resistant), especially when there is also analgesic overuse, are the most disabling forms of migraine. These three disorders (chronic migraine, refractory migraine and medication overuse headache) are particularly difficult to treat. This article reviews their epidemiology, clinical presentation, diagnostic criteria, risk factors, comorbidities and social and personal impact. The therapeutic options available are discussed and focused on a multidisciplinary approach, non-pharmacological interventions treatment of comorbidities and avoiding analgesic overuse. Prophylactic treatments are mandatory and include the oral prophylactic treatments (topiramate), botulinum toxin type A and the novel monoclonal antibodies against calcitonin gene related peptide or its receptor, which are the first migraine preventive medicines developed specifically to target migraine pathogenesis. In refractory cases, multiple therapies are required including neurostimulation.
Autores principais:Parreira, Elsa
Outros Autores:Luzeiro, Isabel; Pereira Monteiro, José Maria
Assunto:Headache Disorders Secondary/chemically induced Migraine Disorders/diagnosis Migraine Disorders/drug therapy Perturbações da Cefaleia Secundários/induzido quimicamente Perturbações de Enxaqueca/diagnóstico Perturbações de Enxaqueca/tratamento farmacológico
Ano:2020
País:Portugal
Tipo de documento:artigo
Tipo de acesso:unknown
Instituição associada:Ordem dos Médicos
Idioma:português
Origem:Acta Médica Portuguesa

Registos relacionados

Registos relacionados